Net Income Loss

Name: Syndax Pharmaceuticals Net Income Loss by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

Syndax Pharmaceuticals·Business Segments·1 segment·Rolls up to Net Income

Breakdown

Segment	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Business Segments	-$84.85M	-$71.85M	-$60.72M	-$68.01M	-$42.67M
Total	-$84.85M	-$71.85M	-$60.72M	-$68.01M	-$42.67M

Business SegmentsView metric